The California District court denied motions for summary judgment of invalidity of Abbott's in situ DNA hybridization patent.
LGC will develop clinical and non-clinical applications for the Ibis T5000 Biosensor System.
Epigenomics, Response Genetics, Exact Sciences
Kevin Ulmer, Patrick Soon-Shiong, Shaun Lonergan
William Moffitt signed a three-year contract to remain president and CEO of Nanosphere, while BioTrove's Al Luderer joined Agendia's supervisory board, and more.
Mort Minaee, Jay Flatley, Mari Baker
The Georgia firm has inked deals with two well-known diagnostics players for development of prostate cancer tests.
The Guardian reports that visa costs could prevent scientists and others from coming to the UK.
The Trump Administration is reconsidering its plan to issue an executive order to require federally funded research to be freely available upon publication, Times Higher Education reports.
Nature News says some preprint repositories may close down due to a lack of funds to cover costs.
In Nature this week: framework for analyzing cancer mutational signatures, treatment resistance in small cell lung cancer followed by increased intratumoral heterogeneity, and more.